RE: NICE Approval8 Aug 2022 14:31
As posted before!
The Nice assessment pathway which the GDR test is now going through is not a regulatory approval, the test has all the approvals needed to be sold to the NHS and in Europe. The Nice assessment is to see weather the test is going to enter best practice treatment guidance. To do this it has to satisfy some financial and clinical need criteria, so if it can be shown it saves money or changes lives considerably then it becomes best practice. This will mean should be used in every NHS hospital (that is the prize). It does not mean that until it is assessed no hospitals will take it up till then or that the large number of private hospitals will not take it up or that other European hospitals will not take it up. So the idea that there is no possibility of sales till it is granted is utterly idiotic. The fact that nice are assessing the GDR test is a huge step forward in the commercialization of the company.